Zobrazeno 1 - 10
of 140 698
pro vyhledávání: '"Cell maturation"'
Autor:
Martin J; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Cheng Q; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Laurent SA; Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany., Thaler FS; Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany., Beenken AE; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Meinl E; Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany., Krönke G; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Hiepe F; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Alexander T; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Oct 09; Vol. 25 (19). Date of Electronic Publication: 2024 Oct 09.
Autor:
Qiang W; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Lu J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Jia Y; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Liu J; Gracell Biotechnologies Ltd, Shanghai, China., Liu J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., He H; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Wang X; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Fan X; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Jin L; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Ruan Q; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Zhang Q; Gracell Biotechnologies Ltd, Shanghai, China., Shen L; Gracell Biotechnologies Ltd, Shanghai, China., Weng L; Gracell Biotechnologies Ltd, Shanghai, China., Cao W; Gracell Biotechnologies Ltd, Shanghai, China., Li W; Gracell Biotechnologies Ltd, Shanghai, China., Du J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Sep 01; Vol. 10 (9), pp. 1259-1263.
Autor:
Munawar U; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Theuersbacher J; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Steinhardt MJ; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Zhou X; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Han S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Nerreter S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Vogt C; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Kurian S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Keller T; Department for Functional Materials in Medicine and Dentistry, University of Würzburg, Würzburg., Regensburger AK; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Teufel E; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Mersi J; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Bittrich M; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Seifert F; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Haider MS; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Rasche L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Hillenkamp J; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Einsele H; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Kampik D; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Kortüm KM; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Waldschmidt JM; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg.
Publikováno v:
Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3670-3680. Date of Electronic Publication: 2024 Nov 01.
Autor:
Chen D; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Zhu Y; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Chen Z; Department of Hematology, Henan Province Hospital of Traditional Chinese Medicine, Institute of Hematology, Henan University of Traditional Chinese Medicine, Zhengzhou, China., Jiang S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China., He H; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Qiang W; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Xiang F; HRAIN Biotechnology Co., Ltd., Shanghai, China., Sun X; HRAIN Biotechnology Co., Ltd., Shanghai, China., Du J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3747-3756.
Autor:
Goel U; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA., Davis J; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Department of Hematology/Medical Oncology, The Medical University of South Carolina, Charleston, South Carolina, USA., Ahmed N; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA., Shaikh H; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USA., Lochner J; University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USA., Abdallah AO; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA., Hashmi H; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Myeloma & Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Anwer F; Cleveland Clinic Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Dec; Vol. 113 (6), pp. 817-823. Date of Electronic Publication: 2024 Aug 27.
Autor:
Guo P; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Wang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China., He H; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Chen D; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Liu J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Qiang W; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Lu J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Liang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China., Du J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
Publikováno v:
Clinical and experimental immunology [Clin Exp Immunol] 2024 Aug 09; Vol. 217 (3), pp. 221-232.
Autor:
Hofer KD; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Wolfensberger N; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Bachofner A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Schneidawind C; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Stühler C; Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland., Bühler MM; Department of Pathology and Molecular Pathology, University Hospital Zürich, Zürich, Switzerland., Abela IA; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich, Switzerland.; Institute of Medical Virology, University of Zürich, Zürich, Switzerland., Müller NJ; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich, Switzerland., Zenz T; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Rösler W; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Khanna N; Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University and University Hospital Basel, Basel, Switzerland., Schneidawind D; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 722-725. Date of Electronic Publication: 2024 May 23.
Autor:
Tryggestad SS; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Roseth IA; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Aass KR; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Ørning NEH; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Mjelle R; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Pathology, St. Olavs University Hospital, Trondheim, Norway., Hella H; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Standal T; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jun 07; Vol. 15, pp. 1393906. Date of Electronic Publication: 2024 Jun 07 (Print Publication: 2024).
Autor:
Lee WH; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Graham CE; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Wiggin HR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Nolan HK; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Graham KJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Korell F; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Barselau AL; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Emmanuel-Alejandro E; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Trailor MA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Gildea JM; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Preffer F; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Gallagher KME; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 May; Vol. 106 (3), pp. 162-170. Date of Electronic Publication: 2024 Feb 28.
Autor:
Gao SQ; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China., Mu J; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China., Li X; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China., Wang J; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China., Cui R; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China., Li JY; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China., Sui T; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China., Deng Q; Department of Hematology, First Central Hospital of Nankai University, Tianjin 300192, China.
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2024 Apr 14; Vol. 45 (4), pp. 378-382.